Search
Displaying 121–130 of 689 for “retinitis clinical trial”
-
AGTC Reports Positive Six-Month Results for XLRP Phase 1/2 Gene Therapy Trial
Research NewsThe company is planning a Phase 3, pivotal trial for end of 2020
-
Research News
Known as antisense oligonucleotides, the treatments performed encouragingly in ProQR’s clinical trials
-
AGTC Announces Results for Achromatopsia Gene Therapy Clinical Trials
Research NewsThe company will continue enrolling younger patients in higher dosing groups.
-
ReNeuron Reports Interim Results for Eight Patients with RP in Phase 2a Trial for Stem Cell Therapy
Research NewsThe Foundation funded earlier lab studies that made the clinical trial possible.
-
ARVO 2019 Highlight: RP Patients in ReNeuron’s Cell Therapy Trial Show Further Vision Improvements
Research NewsThe latest ReNeuron results were presented at the sixth annual Retinal Cell and Gene Therapy Innovation Summit held on April 26 in Vancouver, Canada.
-
Research News
Precise and Sensitive Outcome Measures are Essential for Getting Vision Treatments through Clinical Trials
-
ProQR Doses First Patients in Phase 2/3 Clinical Trials for its USH2A-Exon 13 RNA Therapy
Research NewsThe Sirius trial is for USH2A (exon 13 mutations) patients with advanced vision loss. The Celeste trial is for USH2A (exon 13 mutations) patients with moderate to early vision loss.
-
Research News
Survey results will inform therapy developers and the agenda for a Patient-Focused Drug Development meeting with Food and Drug Administration representatives.
-
Bionic Sight’s Optogenetic Therapy Enables Blind Patients to Detect Light and Motion in Early Trial
Research NewsThe approach holds potential for restoring vision to people with little or no vision
-
Summary of the Ninth Annual Retinal Cell & Gene Therapy Innovation Summit 2024
Foundation NewsIn its ninth year, the Innovation Summit featured more than 30 presentations from retina experts from around the world with nearly 420 people in attendance.
